The company said its full-year 2023 total revenues were $195.3 billion, shareholders' net income was $5.2 billion ($17.39 per share), and adjusted income from operations was $7.4 billion ($25.09 per share). Full-year 2022 net income was $6.7 billion ($21.41 per share).

1. 01

   The company said its full-year 2023 total revenues were $195.3 billion, shareholders' net income was $5.2 billion ($17.39 per share), and adjusted income from operations was $7.4 billion ($25.09 per share). Full-year 2022 net income was $6.7 billion ($21.41 per share).

2. 02

   The company said shareholders' net income for Q4 2023 was $1.0 billion ($3.49 per share), including a net after-tax loss of $552 million ($1.88 per share) tied to the loss on sale of businesses, a deferred tax benefit and a charge for the organizational efficiency plan. Adjusted income from operations for Q4 was $2.0 billion ($6.79 per share).

3. 03

   The company said its adjusted pre-tax income from operations for 2023 was $6,442 million for Evernorth Health Services, $4,478 million for Cigna Healthcare, and $(1,602) million for Corporate and Other Operations. The company cited the absence of income from divested businesses as the main factor behind the increase in the Corporate loss.

4. 04

   The company outlined a full-year 2024 outlook of at least $8.025 billion in adjusted income from operations (at least $28.25 per share) and at least $235.0 billion in adjusted revenues. Its board set the quarterly dividend at $1.40 per share, an increase of 14%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.